Antitumor activity of α-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells

Oncology Research

Volumn 12, Issue 2, 2000, Pages 51-58

  Nakagawa, Ryusuke ^a   Serizawa, Isao ^a   Motoki, Kazuhiro ^a   Sato, Miyuki ^a   Ueno, Hitomi ^a   Iijima, Rieko ^a   Nakamura, Hiromi ^a   Shimosaka, Akihiro ^a   Koezuka, Yasuhiko ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

KRN7000; Macrophages; NK cells; NKT cells; Galactosylceramide

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ANTIGEN; ANTINEOPLASTIC AGENT; CD161 ANTIGEN; CD8 ANTIGEN; DIFFERENTIATION ANTIGEN; GALACTOSYLCERAMIDE; INTERLEUKIN 12; LECTIN; MEMBRANE ANTIGEN; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; EXPERIMENTAL MELANOMA; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; MACROPHAGE; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; TIME;

ANIMALS; ANTIGENS; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; FEMALE; GALACTOSYLCERAMIDES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; LECTINS, C-TYPE; LIVER NEOPLASMS; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTEINS; RECOMBINANT PROTEINS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033650499     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747521     Document Type: Article

References (31)

1. Oberfield, R. A.; McCaffrey, J. A.; Polio, J. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 44:414-423; 1979.
2. Nakagawa, R.; Motoki, K.; Ueno, H.; Iijima, R.; Nakamura, H.; Kobayashi, E.; Shimosaka, A.; Koezuka, Y. Treatment of hepatic metastasis of the Colon26 adenocarcinoma with α-galactosylceramide, KRN7000. Cancer Res. 58:1202-1207; 1998.
3. Nakagawa, R.; Motoki, K.; Nakamura, H.; Ueno, H.; Iijima, R.; Yamauchi, A.; Tsuyuki, S.; Inamoto, T.; Koezuka, Y. Antitumor activity of α-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production. Oncol. Res. 10: 561-568; 1998.
4. Kobayashi, E.; Motoki, K.; Uchida, T.; Fukushima, H.; Koezuka, Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7:529-534; 1995.
5. Yamaguchi, Y.; Ueno, H.; Maeda, K.; Motoki, K.; Kobayashi, E.; Inoue, U.; Fukushima, H.; Koezuka, Y. Enhancing effects of (2S,3S,4R) - 1 - O - (α - D - galactopyranosyl) - 2 - (N - hexacosanoyl amino)-1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol. Res. 8:399-407; 1996.
6. Morita, M.; Motoki, K.; Akimoto, K.; Natori, T.; Sakai, T.; Sawa, E.; Yamaji, K.; Koezuka, Y.; Kobayashi, E.; Fukushima, H. Structure-activity relationship of α-galactosylceramides against B16-bearing mice. J. Med. Chem. 38:2176-2187; 1995.
7. Eisenthal, A.; Cameron, R. B.; Rosenberg, S. A. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-γ and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody. J. Immunol. 144:4463-4471; 1990.
8. Brunda, M. J.; Luistro, L.; Warrier, R. R.; Wright, R. B.; Hubbard, B. R.; Murphy, M.; Wolf, S. F.; Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223-1230; 1993.
9. Roh, M.; Kahky, M. P.; Oyedeji, C.; Klostergaard, J.; Wang, L.; Curley, S. A.; Lotzova, E. Murine kuffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases. Clin. Exp. Metastasis 10:317-327; 1992.
10. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154:4333-4340; 1995.
11. Cui, J.; Shin, T.; Kawano, T.; Sato, H.; Kondo, E.; Toura, I.; Kaneko, Y.; Koseki, H.; Kanno, M.; Taniguchi, M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623-1626; 1997.
12. Kitamura, H.; Iwakabe, K.; Yahata, T.; Nishimura, S.; Ohta, A.; Ohmi, Y.; Sato, M.; Takeda, K.; Okumura, K.; Van Kaer, L.; Kawano, T.; Taniguchi, M.; Nishimura, T. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immuno-potentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121-1127; 1999.
13. +NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163:93-101; 1999.
14. Kawano, T.; Cui, J.; Koezuka, Y.; Toura, I.; Kaneko, Y.; Sato, H.; Kondo, E.; Harada, M.; Koseki, H.; Nakayama, T.; Tanaka, Y.; Taniguchi, M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95:5690-5693; 1998.
15. Zhang, S-R.; Salup, R. R.; Urias, P. E.; Twilley, T. A.; Talmadge, J. E.; Herberman, R. B.; Wiltrout, R. H. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2. Cancer Immunol. Immunother. 21:19-25; 1986.
16. Doherty, P. C.; Knowles, B. B.; Wettstein, P. J. Immunological surveillance of tumors in the context of major histocompatibility restriction of T-cell function. Adv. Cancer Res. 42:1-65; 1984.
17. Aebersold, P.; Hyatt, C.; Johnson, S.; Hines, K.; Korcak, L.; Sanders, M.; Lotze, M.; Topalian, S.; Yang, J.; Rosenberg, S. A. Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes. J. Natl. Cancer Inst. 83:932-937; 1991.
18. Tepper, R. I.; Coffman, R. L.; Leder, P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257: 548-551; 1992.
19. Burdin, N.; Brossay, L.; Kronenberg, M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells toward Th2 cytokine synthesis. Eur. J. Immunol. 29:2014-2025; 1999.
20. Singh, N.; Hong, S.; Scherer, D. C.; Serizawa, I.; Burdin, N.; Kronenberg, M.; Koezuka, Y.; Van Kaer, L. Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:2373-2377; 1999.
21. Zen, H. J.; Hurd, S.; Storkus, W. J.; Lotze, M. T. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: Implications for the immunotherapy of cancer. J. Immunother. 14:155-161; 1993.
22. Jewett, A.; Bonavida, B. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-α and IFN-γ secretion. Cell Immunol. 154:273-286; 1994.
23. Kawano, T.; Cui, J.; Koezuka, Y.; Toura, I.; Kaneko, Y.; Motoki, K.; Ueno, H.; Nakagawa, R.; Sato, H.; Kondo, E.; Koseki, H.; Taniguchi, M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1627-1629; 1997.
24. Burdin, N.; Brossay, L.; Koezuka, Y.; Smiley, S. T.; Grusby, M. J.; Gui, M.; Taniguchi, M.; Hayakawa, K.; Kronenberg, M. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulate Vα14+ NKT lymphocytes. J. Immunol. 161:3271-3281; 1998.
25. Carnaud, C.; Lee, D.; Donnars, O.; Park, S-H.; Beavis, A.; Koezuka, Y.; Bendelac, A. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650; 1999.
26. Eberl, G.; MacDonald, H. R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985-992; 2000.
27. Spada, F. M.; Koezuka, Y.; Porcelli, S. A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1529-1534; 1998.
28. Couedel, C.; Peyrat, M-A.; Brossay, L.; Koezuka, Y.; Porcelli, S. A.; Davodeau, F.; Bonneville, M. Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR. Eur. J. Immunol. 28:4391-4397; 1998.
29. Nieda, M.; Nicol, A.; Koezuka, Y.; Kikuchi, A.; Takahashi, T.; Nakamura, H.; Furukawa, H.; Yabe, T.; Ishikawa, Y.; Tadokoro, K.; Juji, T. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum. Immunol. 60:10-19; 1999.
30. Brossay, L.; Chioda, M.; Burdin, N.; Koezuka, Y.; Casorati, G.; Dellabona, P.; Kronenberg, M. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521-1528; 1998.
31. + T cells. Immunology 98: 557-563; 1999.